Skip to main content
James Ferrara, MD, Hematology, New York, NY

JamesL MFerraraMD

Hematology New York, NY

Hematologic Oncology

Professor and Director of Hematologic Malignancies Translational Research Center

Dr. Ferrara is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ferrara's full profile

Already have an account?

  • Office

    10 E 102nd St
    New York, NY 10029
    Phone+1 212-241-6756
    Fax+1 646-537-9576

Education & Training

  • Oxford University
    Oxford UniversityD.Sc, Medical Sciences, 2009 - 2009
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1982 - 1985
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1981 - 1982
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1980 - 1981
  • Georgetown University
    Georgetown UniversityMA, Cum Laude, 1980 - 1980
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1980
  • Oxford University
    Oxford UniversityMA, Literae Humaniores, 1976 - 1976
  • Xavier University
    Xavier UniversityH.A.B, Summa Cum Laude, 1974 - 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2015 - 2026
  • MI State Medical License
    MI State Medical License 1998 - 2015

Awards, Honors, & Recognition

  • Ward-Coleman Chair in Cancer Medicine Icahn School of Medicine, 2014
  • Nobel Lecture Karolinska Institutet, Stockholm, Sweden, 2012
  • Visiting Fellowship All Soul’s College, Oxford, England, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused p...  
    Smith BR, Guinan EC, Parkman R, Ferrara JLM, Levey RH, Nathan DG, Rappeport JM, Transplantation
  • Cutaneous acute graft-versus- host disease to minor histocompatibility antigens in a murine model: Histologic analysis and correlation to clinic disease.  
    Ferrara JLM, Guillén FJ, Sleckman B, Burakoff SJ, Murphy GF, J Invest Dermatol
  • Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model: Evidence that large granular lymphocytes are effector cells...  
    Guillén FJ, Ferrara JLM, Hancock WW, Messadi D, Fonferko E, Burakoff SJ, Murphy GF, Lab Invest
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
    James L. M. Ferrara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • The Evolving Treatment Landscape for Patients with GvHD: More Options, More Decisions, Better Outcomes! 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Reining in Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • Reining in Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Join now to see all

Other

Press Mentions

  • Could a Vaccine Passport Soon Be Your Ticket to a Quarantine-Free Vacation?
    Could a Vaccine Passport Soon Be Your Ticket to a Quarantine-Free Vacation?May 4th, 2021
  • Novartis, Juno Face Production Hurdles for New Blood Cancer Drugs
    Novartis, Juno Face Production Hurdles for New Blood Cancer DrugsJanuary 13th, 2016
  • Expert Discusses Approval of First CAR T-cell Therapy
    Expert Discusses Approval of First CAR T-cell TherapySeptember 19th, 2017

Professional Memberships